Logo image of EXPE

EXPEDIA GROUP INC (EXPE) Stock Fundamental Analysis

USA - NASDAQ:EXPE - US30212P3038 - Common Stock

220 USD
-0.47 (-0.21%)
Last: 10/31/2025, 8:00:02 PM
220 USD
0 (0%)
After Hours: 10/31/2025, 8:00:02 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to EXPE. EXPE was compared to 132 industry peers in the Hotels, Restaurants & Leisure industry. While EXPE belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. EXPE has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year EXPE was profitable.
In the past year EXPE had a positive cash flow from operations.
In multiple years EXPE reported negative net income over the last 5 years.
Of the past 5 years EXPE 4 years had a positive operating cash flow.
EXPE Yearly Net Income VS EBIT VS OCF VS FCFEXPE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

1.2 Ratios

EXPE has a Return On Assets of 4.10%. This is in the better half of the industry: EXPE outperforms 60.15% of its industry peers.
EXPE has a better Return On Equity (132.42%) than 97.74% of its industry peers.
EXPE has a better Return On Invested Capital (17.00%) than 85.71% of its industry peers.
EXPE had an Average Return On Invested Capital over the past 3 years of 10.99%. This is in line with the industry average of 10.72%.
The last Return On Invested Capital (17.00%) for EXPE is above the 3 year average (10.99%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.1%
ROE 132.42%
ROIC 17%
ROA(3y)3.61%
ROA(5y)-0.96%
ROE(3y)48.88%
ROE(5y)5.49%
ROIC(3y)10.99%
ROIC(5y)N/A
EXPE Yearly ROA, ROE, ROICEXPE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

EXPE's Profit Margin of 7.90% is fine compared to the rest of the industry. EXPE outperforms 66.92% of its industry peers.
EXPE's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 12.15%, EXPE is doing good in the industry, outperforming 64.66% of the companies in the same industry.
EXPE's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 89.58%, EXPE belongs to the top of the industry, outperforming 98.50% of the companies in the same industry.
EXPE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.15%
PM (TTM) 7.9%
GM 89.58%
OM growth 3Y58.59%
OM growth 5Y8.82%
PM growth 3YN/A
PM growth 5Y14%
GM growth 3Y2.82%
GM growth 5Y1.74%
EXPE Yearly Profit, Operating, Gross MarginsEXPE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EXPE is creating value.
The number of shares outstanding for EXPE has been reduced compared to 1 year ago.
The number of shares outstanding for EXPE has been reduced compared to 5 years ago.
Compared to 1 year ago, EXPE has an improved debt to assets ratio.
EXPE Yearly Shares OutstandingEXPE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
EXPE Yearly Total Debt VS Total AssetsEXPE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

EXPE has an Altman-Z score of 1.17. This is a bad value and indicates that EXPE is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.17, EXPE is not doing good in the industry: 61.65% of the companies in the same industry are doing better.
EXPE has a debt to FCF ratio of 3.11. This is a good value and a sign of high solvency as EXPE would need 3.11 years to pay back of all of its debts.
The Debt to FCF ratio of EXPE (3.11) is better than 81.20% of its industry peers.
A Debt/Equity ratio of 5.34 is on the high side and indicates that EXPE has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 5.34, EXPE is doing worse than 60.90% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 5.34
Debt/FCF 3.11
Altman-Z 1.17
ROIC/WACC2.23
WACC7.62%
EXPE Yearly LT Debt VS Equity VS FCFEXPE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B -4B 6B 8B

2.3 Liquidity

A Current Ratio of 0.75 indicates that EXPE may have some problems paying its short term obligations.
EXPE's Current ratio of 0.75 is on the low side compared to the rest of the industry. EXPE is outperformed by 60.90% of its industry peers.
A Quick Ratio of 0.75 indicates that EXPE may have some problems paying its short term obligations.
EXPE's Quick ratio of 0.75 is in line compared to the rest of the industry. EXPE outperforms 43.61% of its industry peers.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.75
EXPE Yearly Current Assets VS Current LiabilitesEXPE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

5

3. Growth

3.1 Past

EXPE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.29%, which is quite impressive.
The Earnings Per Share has been growing by 14.87% on average over the past years. This is quite good.
EXPE shows a small growth in Revenue. In the last year, the Revenue has grown by 5.69%.
EXPE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.56% yearly.
EPS 1Y (TTM)21.29%
EPS 3Y104.08%
EPS 5Y14.87%
EPS Q2Q%20.8%
Revenue 1Y (TTM)5.69%
Revenue growth 3Y16.77%
Revenue growth 5Y2.56%
Sales Q2Q%6.41%

3.2 Future

EXPE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.50% yearly.
Based on estimates for the next years, EXPE will show a small growth in Revenue. The Revenue will grow by 6.25% on average per year.
EPS Next Y16.21%
EPS Next 2Y18.27%
EPS Next 3Y18.05%
EPS Next 5Y15.5%
Revenue Next Year5.5%
Revenue Next 2Y5.96%
Revenue Next 3Y6.45%
Revenue Next 5Y6.25%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EXPE Yearly Revenue VS EstimatesEXPE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
EXPE Yearly EPS VS EstimatesEXPE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 20 30

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.72 indicates a correct valuation of EXPE.
Based on the Price/Earnings ratio, EXPE is valued a bit cheaper than the industry average as 72.93% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of EXPE to the average of the S&P500 Index (26.11), we can say EXPE is valued slightly cheaper.
With a Price/Forward Earnings ratio of 12.85, EXPE is valued correctly.
76.69% of the companies in the same industry are more expensive than EXPE, based on the Price/Forward Earnings ratio.
EXPE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.55.
Industry RankSector Rank
PE 16.72
Fwd PE 12.85
EXPE Price Earnings VS Forward Price EarningsEXPE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EXPE is valued a bit cheaper than the industry average as 63.16% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, EXPE is valued cheaply inside the industry as 84.21% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.63
EV/EBITDA 10.28
EXPE Per share dataEXPE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100

4.3 Compensation for Growth

EXPE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of EXPE may justify a higher PE ratio.
A more expensive valuation may be justified as EXPE's earnings are expected to grow with 18.05% in the coming years.
PEG (NY)1.03
PEG (5Y)1.12
EPS Next 2Y18.27%
EPS Next 3Y18.05%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.73%, EXPE is not a good candidate for dividend investing.
EXPE's Dividend Yield is a higher than the industry average which is at 4.12.
With a Dividend Yield of 0.73, EXPE pays less dividend than the S&P500 average, which is at 2.37.
Industry RankSector Rank
Dividend Yield 0.73%

5.2 History

EXPE has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
EXPE Yearly Dividends per shareEXPE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DPN/A
EPS Next 2Y18.27%
EPS Next 3Y18.05%
EXPE Yearly Income VS Free CF VS DividendEXPE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

EXPEDIA GROUP INC

NASDAQ:EXPE (10/31/2025, 8:00:02 PM)

After market: 220 0 (0%)

220

-0.47 (-0.21%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-06 2025-11-06/amc
Inst Owners102.64%
Inst Owner Change-0.51%
Ins Owners0.51%
Ins Owner Change0.26%
Market Cap27.22B
Revenue(TTM)14.02B
Net Income(TTM)1.11B
Analysts72.09
Price Target229.99 (4.54%)
Short Float %5.7%
Short Ratio4.1
Dividend
Industry RankSector Rank
Dividend Yield 0.73%
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date08-28 2025-08-28 (0.4)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.21%
Min EPS beat(2)1.46%
Max EPS beat(2)20.96%
EPS beat(4)3
Avg EPS beat(4)9.14%
Min EPS beat(4)-0.95%
Max EPS beat(4)20.96%
EPS beat(8)7
Avg EPS beat(8)30.51%
EPS beat(12)8
Avg EPS beat(12)-12.48%
EPS beat(16)12
Avg EPS beat(16)3.75%
Revenue beat(2)1
Avg Revenue beat(2)-1.36%
Min Revenue beat(2)-2.83%
Max Revenue beat(2)0.11%
Revenue beat(4)2
Avg Revenue beat(4)-1.07%
Min Revenue beat(4)-3.22%
Max Revenue beat(4)1.66%
Revenue beat(8)3
Avg Revenue beat(8)-0.81%
Revenue beat(12)3
Avg Revenue beat(12)-1.4%
Revenue beat(16)5
Avg Revenue beat(16)-0.63%
PT rev (1m)1.09%
PT rev (3m)19.03%
EPS NQ rev (1m)0.39%
EPS NQ rev (3m)0.97%
EPS NY rev (1m)0.47%
EPS NY rev (3m)0.54%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)1.89%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)1.04%
Valuation
Industry RankSector Rank
PE 16.72
Fwd PE 12.85
P/S 1.94
P/FCF 13.63
P/OCF 9.8
P/B 32.56
P/tB N/A
EV/EBITDA 10.28
EPS(TTM)13.16
EY5.98%
EPS(NY)17.12
Fwd EY7.78%
FCF(TTM)16.14
FCFY7.34%
OCF(TTM)22.45
OCFY10.21%
SpS113.3
BVpS6.76
TBVpS-55.12
PEG (NY)1.03
PEG (5Y)1.12
Graham Number44.73
Profitability
Industry RankSector Rank
ROA 4.1%
ROE 132.42%
ROCE 23.13%
ROIC 17%
ROICexc 181.1%
ROICexgc N/A
OM 12.15%
PM (TTM) 7.9%
GM 89.58%
FCFM 14.25%
ROA(3y)3.61%
ROA(5y)-0.96%
ROE(3y)48.88%
ROE(5y)5.49%
ROIC(3y)10.99%
ROIC(5y)N/A
ROICexc(3y)20.29%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)14.96%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y125.83%
ROICexc growth 5Y22.57%
OM growth 3Y58.59%
OM growth 5Y8.82%
PM growth 3YN/A
PM growth 5Y14%
GM growth 3Y2.82%
GM growth 5Y1.74%
F-Score8
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 5.34
Debt/FCF 3.11
Debt/EBITDA 1.74
Cap/Depr 90.29%
Cap/Sales 5.57%
Interest Coverage 7.92
Cash Conversion 108.18%
Profit Quality 180.4%
Current Ratio 0.75
Quick Ratio 0.75
Altman-Z 1.17
F-Score8
WACC7.62%
ROIC/WACC2.23
Cap/Depr(3y)92.88%
Cap/Depr(5y)87.19%
Cap/Sales(3y)5.93%
Cap/Sales(5y)8.19%
Profit Quality(3y)403.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.29%
EPS 3Y104.08%
EPS 5Y14.87%
EPS Q2Q%20.8%
EPS Next Y16.21%
EPS Next 2Y18.27%
EPS Next 3Y18.05%
EPS Next 5Y15.5%
Revenue 1Y (TTM)5.69%
Revenue growth 3Y16.77%
Revenue growth 5Y2.56%
Sales Q2Q%6.41%
Revenue Next Year5.5%
Revenue Next 2Y5.96%
Revenue Next 3Y6.45%
Revenue Next 5Y6.25%
EBIT growth 1Y7.31%
EBIT growth 3Y85.19%
EBIT growth 5Y11.61%
EBIT Next Year138.56%
EBIT Next 3Y42.43%
EBIT Next 5Y27.05%
FCF growth 1Y-13.96%
FCF growth 3Y-8.85%
FCF growth 5Y7.7%
OCF growth 1Y-11.08%
OCF growth 3Y-6.28%
OCF growth 5Y2.2%

EXPEDIA GROUP INC / EXPE FAQ

Can you provide the ChartMill fundamental rating for EXPEDIA GROUP INC?

ChartMill assigns a fundamental rating of 6 / 10 to EXPE.


Can you provide the valuation status for EXPEDIA GROUP INC?

ChartMill assigns a valuation rating of 6 / 10 to EXPEDIA GROUP INC (EXPE). This can be considered as Fairly Valued.


What is the profitability of EXPE stock?

EXPEDIA GROUP INC (EXPE) has a profitability rating of 8 / 10.


What is the financial health of EXPEDIA GROUP INC (EXPE) stock?

The financial health rating of EXPEDIA GROUP INC (EXPE) is 4 / 10.